Excipients

Oct 26, 2015
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
Parteck SRP 80 is a functional excipient designed for sustained-release matrix tablets.
Oct 26, 2015
By Pharmaceutical Technology Editors
Dow introduces solvent-free productivity technology for coating barrier membranes.
Oct 23, 2015
By Pharmaceutical Technology Editors
The excipient supplier's cGMP practices have been certified as meeting EXCiPACT standards
Oct 15, 2015
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
Dow’s AFFINISOL HPMC HME is a new cellulosic polymer designed to enhance solubilization and inhibit recrystallization of APIs in hot-melt extrusion (HME) formulations.
Oct 08, 2015
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
A collaboration between Grace and Formac Pharmaceuticals results in drug delivery option for poorly-soluble APIs.
Oct 02, 2015
Pharmaceutical Technology
Safer solid reagents and new coupling chemistry are important developments.
Sep 16, 2015
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
EMD Millipore, the Life Science business of Merck KGaA, introduced expanded documentation and regulatory information for its Emprove portfolio of pharmaceutical raw materials, which include excipients, process chemicals, and APIs.
Sep 08, 2015
Pharmaceutical Technology
As EU supplier risk assessment deadlines approach, a number of voluntary third-party auditing and certification options are available. Will more excipient suppliers, and drug manufacturers, use them?
Aug 24, 2015
Randy Wald, senior research fellow at Bend Research, part of Capsugel Dosage Form Solutions shares insights on trends shaping the evolving solid dosage manufacturing landscape, including advances in excipients and the impact on formulation development and manufacturing processes.
Aug 15, 2015
Pharmaceutical Technology
The complex task of stabilizing proteins is made more challenging due to the limited number of approved excipients.
native1_300x100
lorem ipsum